CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 107 enrolled
Drug / intervention
Lithium +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02870283
NCT02870283Phase 4Completed
CompareCT.gov

Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Mood Disorders Through Resources Available in Brazilian Public Health

Federal University of Rio Grande do Sul·interventional·Posted Aug 17, 2016·Updated Nov 20, 2020

In Brief

A Phase 4 clinical trial evaluating Lithium, Valproic Acid, and 1 other intervention for Bipolar Disorder. Completed, enrolled 107 participants.

Detailed Summary

To evaluate the effectiveness of three systematic interventions for Bipolar Disorder (BD) mixed episodes using medications available in the Brazilian Public Healthcare System (SUS), and assessment of the quality of life of these patients. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of bipolar mixed episodes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 17, 2016
Enrollment StartMay 1, 2010
Primary CompletionNov 1, 2014
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.9 years ago

Interventions

Lithiumdrug

Valproic Aciddrug

Carbamazepinedrug